newsfilter
← Latest News
Business Wire·

Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025

- Announced positive Phase 2 Data for CYB003, Demonstrating Breakthrough 12-Month Efficacy in Treating Major Depressive Disorder ("MDD") - - Initiated PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating